234 filings
Page 2 of 12
8-K
ukqmol30
12 Aug 21
Casi Pharmaceuticals Announces Second Quarter 2021
4:32pm
8-K
ao0c6u052 pm2g9o2cs
28 Jul 21
Departure of Directors or Certain Officers
4:01pm
8-K/A
8yj09 nsgsry
21 Jun 21
Departure of Directors or Certain Officers
5:26pm
8-K
zlvs ywzdm
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
b37srk3 817
13 May 21
Casi Pharmaceuticals Announces First Quarter 2021 Financial Results
4:02pm
8-K
ln7mif0 6o04
30 Apr 21
Departure of Directors or Certain Officers
4:01pm
8-K
p17o415kid 9vc1e9ck
30 Mar 21
Announces Full Year 2020 Financial Results
12:00am
8-K
03sj7
26 Mar 21
Casi Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:01pm
8-K
cl1gd8wwc3
25 Mar 21
Departure of Directors or Certain Officers
4:01pm
8-K
6qb5slis6jupxl27ou
23 Mar 21
Other Events
4:04pm
8-K
q1vttv1irbrjf
12 Mar 21
Corporate Presentation March 2021
9:20am
8-K
c76178w 81c91grq4a
8 Mar 21
Entry into a Material Definitive Agreement
4:01pm
8-K
hc0i5imf
16 Feb 21
Casi Pharmaceuticals Announces Preliminary Fourth Quarter and Full-Year 2020 Revenues
4:01pm
8-K
rqbh5
10 Feb 21
Amendments to Articles of Incorporation or Bylaws
5:04pm
8-K
kp8sha7h29vdc
28 Jan 21
Casi Pharmaceuticals Partner, Bioinvent, Presents
4:02pm
8-K
a8capem h27
23 Dec 20
Receives China Breakthrough Therapy Designation
4:01pm
8-K
sc21rjqotc
16 Dec 20
Casi Pharmaceuticals Announces Appointment of Chief Financial Officer
4:43pm
8-K
lqb 83sxkd
19 Nov 20
Casi Pharmaceuticals Announces Partner Juventas
4:05pm
8-K
0lrjx
9 Nov 20
Casi Pharmaceuticals Announces Third Quarter 2020
4:30pm
8-K
hxbq9vm
28 Oct 20
Entry into a Material Definitive Agreement
4:26pm